JPY 1829.0
(-4.19%)
Breakdown | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Operating Cash Flow | 253.67 Million | 286.66 Million | 316.54 Million | 291.67 Million |
Net Income | 317.69 Million | 322.82 Million | 261.64 Million | 134.53 Million |
Depreciation & Amortization | 71.33 Million | 38.02 Million | 36.63 Million | 33.31 Million |
Deferred income taxes | - | - | - | - |
Stock-based compensation | - | - | - | - |
Change in working capital | -86.49 Million | 38.45 Million | 88.12 Million | 130.13 Million |
Other non-cash items | 42.98 Million | 3.32 Million | -1.38 Million | 14.03 Million |
Investing Cash Flow | -202.57 Million | -89.85 Million | -69.27 Million | -74.43 Million |
Investments in PPE | -123.19 Million | -89.85 Million | -68.11 Million | -44.15 Million |
Acquisitions | - | - | - | - |
Investment purchases | - | - | - | - |
Sales/Maturities of investments | - | - | - | - |
Other Investing Activities | -79.37 Million | -1000.00 | -1.15 Million | -30.28 Million |
Financing Cash Flow | 519.93 Million | -122.79 Million | 41.24 Million | -49.84 Million |
Debt repayment | -63.05 Million | -122.79 Million | -40.37 Million | -49.84 Million |
Dividends payments | - | - | - | - |
Common Stock Repurchased | - | - | - | - |
Common Stock Issuance | 598.1 Million | - | - | - |
Other Financing Activities | -1000.00 | - | 871 Thousand | - |
Accounts receivables | -19 Million | - | - | - |
Accounts payables | - | - | - | - |
Inventory | - | - | - | - |
Other working capital | 35 Million | - | - | - |
Cash at beginning of period | 890.8 Million | 811.09 Million | 518.38 Million | 350.74 Million |
Cash at end of period | 1.46 Billion | 890.8 Million | 811.09 Million | 518.38 Million |
Capital Expenditure | -123.19 Million | -89.85 Million | -68.11 Million | -44.15 Million |
Effect of forex changes on cash | 6.57 Million | 5.69 Million | 4.18 Million | 255 Thousand |
Net cash flow / Change in cash | 577.6 Million | 79.71 Million | 292.7 Million | 167.64 Million |
Free Cash Flow | 130.47 Million | 196.81 Million | 248.42 Million | 247.51 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 34 Million | 53 Million | 317.69 Million | 75 Million | 63 Million | 31 Million |
Depreciation & Amortization | - | - | 71.33 Million | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | -86.49 Million | - | - | - |
Other non-cash items | -34 Million | -53 Million | 42.98 Million | -75 Million | -63 Million | -31 Million |
Investing Cash Flow | - | - | -202.57 Million | - | - | - |
Investments in PPE | - | - | -123.19 Million | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | -79.37 Million | - | - | - |
Financing Cash Flow | - | - | 519.93 Million | - | - | - |
Debt repayment | - | - | -63.05 Million | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | 598.1 Million | - | - | - |
Other Financing Activities | - | - | -1000.00 | - | - | - |
Accounts receivables | - | - | -19 Million | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | 35 Million | - | - | - |
Cash at beginning of period | - | - | 890.8 Million | - | - | - |
Cash at end of period | - | - | 1.46 Billion | - | - | - |
Capital Expenditure | - | - | -123.19 Million | - | - | - |
Effect of forex changes on cash | - | - | 6.57 Million | - | - | - |
Net cash flow / Change in cash | - | - | 577.6 Million | - | - | - |
Free Cash Flow | - | - | 130.47 Million | - | - | - |
EPIGRAL
GOT
DNAX
KPC
NENTF
CASH